Perspective Therapeutics (CATX) Retained Earnings (2011 - 2026)

Perspective Therapeutics has disclosed Retained Earnings across 16 years of filings, most recently posting -$387.8 million for Q2 2026.

• In Q2 2026, Retained Earnings fell 42.89% year-over-year to -$387.8 million; the TTM figure through Jun 2026 stood at -$387.8 million (down 42.89% YoY), while the FY2025 annual figure was -$334.8 million, down 44.5% from the prior year.
• Retained Earnings came in at -$387.8 million for Q2 2026 at Perspective Therapeutics, down from -$361.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$96.5 million in Q1 2022 to a low of -$387.8 million in Q2 2026.
• Average Retained Earnings over 5 years is -$198.6 million, with a median of -$170.6 million recorded in 2024.
• Year-over-year, Retained Earnings slipped 6.93% in 2022 and sank 55.22% in 2025.
• Over 5 years, Retained Earnings stood at -$105.9 million in 2022, then plunged by 43.9% to -$152.4 million in 2023, then tumbled by 52.01% to -$231.7 million in 2024, then plunged by 44.5% to -$334.8 million in 2025, then dropped by 15.82% to -$387.8 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$387.8 million in Q2 2026, -$361.0 million in Q1 2026, and -$334.8 million in Q4 2025.